As the PNPLA3 variant allele is the most frequent risk modifier among cirrhotic patients, we analysed a larger group of cirrhotic patients to establish the impact of concomitant carriage of both variants on the severity of liver disease in the liver transplant settings. This evidence concerns the gene PNPLA3 and liver disorder.